Index by author

October 01 2012; volume 30 issue 4

C

  1. Chua, Elizabeth L.

    1. Diabetic Ketoacidosis as a Presenting Feature of Acromegaly: When Excess Hormone Meets Hormone Deficiency
      Lisa R. Simmons, Kiernan Hughes, Tania P. Markovic and Elizabeth L. Chua
      Clinical Diabetes 2012 Oct; 30 (4): 170-172. https://doi.org/10.2337/diaclin.30.4.170

  2. Close, Kelly L.

    1. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
      Lisa S. Rotenstein, Nina Ran, Joseph P. Shivers, Mark Yarchoan and Kelly L. Close
      Clinical Diabetes 2012 Oct; 30 (4): 138-150. https://doi.org/10.2337/diaclin.30.4.138

F

  1. Fortmann, Addie L.

    1. Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice? Implications from 15 Years of Testing, Translating, and Implementing Community-Based, Culturally Tailored Diabetes Management Programs
      Athena Philis-Tsimikas, Todd P. Gilmer, James Schultz, Chris Walker, Addie L. Fortmann and Linda C. Gallo
      Clinical Diabetes 2012 Oct; 30 (4): 156-163. https://doi.org/10.2337/diaclin.30.4.156

G

  1. Gallo, Linda C.

    1. Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice? Implications from 15 Years of Testing, Translating, and Implementing Community-Based, Culturally Tailored Diabetes Management Programs
      Athena Philis-Tsimikas, Todd P. Gilmer, James Schultz, Chris Walker, Addie L. Fortmann and Linda C. Gallo
      Clinical Diabetes 2012 Oct; 30 (4): 156-163. https://doi.org/10.2337/diaclin.30.4.156

  2. Gavlak, Gina

    1. Stopping Diabetes Through Advocacy: The Role of Health Care Professionals
      Daniel Lorber and Gina Gavlak
      Clinical Diabetes 2012 Oct; 30 (4): 179-182. https://doi.org/10.2337/diaclin.30.4.179

  3. Gilmer, Todd P.

    1. Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice? Implications from 15 Years of Testing, Translating, and Implementing Community-Based, Culturally Tailored Diabetes Management Programs
      Athena Philis-Tsimikas, Todd P. Gilmer, James Schultz, Chris Walker, Addie L. Fortmann and Linda C. Gallo
      Clinical Diabetes 2012 Oct; 30 (4): 156-163. https://doi.org/10.2337/diaclin.30.4.156

H

  1. Hughes, Kiernan

    1. Diabetic Ketoacidosis as a Presenting Feature of Acromegaly: When Excess Hormone Meets Hormone Deficiency
      Lisa R. Simmons, Kiernan Hughes, Tania P. Markovic and Elizabeth L. Chua
      Clinical Diabetes 2012 Oct; 30 (4): 170-172. https://doi.org/10.2337/diaclin.30.4.170

L

  1. Lorber, Daniel

    1. Stopping Diabetes Through Advocacy: The Role of Health Care Professionals
      Daniel Lorber and Gina Gavlak
      Clinical Diabetes 2012 Oct; 30 (4): 179-182. https://doi.org/10.2337/diaclin.30.4.179

M

  1. Makaya, Tafadzwa

    1. Pitfalls in Diagnosing the Simultaneous Presentation of Type 1 Diabetes and Thyrotoxicosis in a Pediatric Patient
      Tafadzwa Makaya, Jerry K. H. Wales and Katherine J. Price
      Clinical Diabetes 2012 Oct; 30 (4): 168-169. https://doi.org/10.2337/diaclin.30.4.168

  2. Markovic, Tania P.

    1. Diabetic Ketoacidosis as a Presenting Feature of Acromegaly: When Excess Hormone Meets Hormone Deficiency
      Lisa R. Simmons, Kiernan Hughes, Tania P. Markovic and Elizabeth L. Chua
      Clinical Diabetes 2012 Oct; 30 (4): 170-172. https://doi.org/10.2337/diaclin.30.4.170

P

  1. Philis-Tsimikas, Athena

    1. Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice? Implications from 15 Years of Testing, Translating, and Implementing Community-Based, Culturally Tailored Diabetes Management Programs
      Athena Philis-Tsimikas, Todd P. Gilmer, James Schultz, Chris Walker, Addie L. Fortmann and Linda C. Gallo
      Clinical Diabetes 2012 Oct; 30 (4): 156-163. https://doi.org/10.2337/diaclin.30.4.156

  2. Price, Katherine J.

    1. Pitfalls in Diagnosing the Simultaneous Presentation of Type 1 Diabetes and Thyrotoxicosis in a Pediatric Patient
      Tafadzwa Makaya, Jerry K. H. Wales and Katherine J. Price
      Clinical Diabetes 2012 Oct; 30 (4): 168-169. https://doi.org/10.2337/diaclin.30.4.168

R

  1. Ran, Nina

    1. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
      Lisa S. Rotenstein, Nina Ran, Joseph P. Shivers, Mark Yarchoan and Kelly L. Close
      Clinical Diabetes 2012 Oct; 30 (4): 138-150. https://doi.org/10.2337/diaclin.30.4.138

  2. Rotenstein, Lisa S.

    1. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
      Lisa S. Rotenstein, Nina Ran, Joseph P. Shivers, Mark Yarchoan and Kelly L. Close
      Clinical Diabetes 2012 Oct; 30 (4): 138-150. https://doi.org/10.2337/diaclin.30.4.138

S

  1. Schultz, James

    1. Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice? Implications from 15 Years of Testing, Translating, and Implementing Community-Based, Culturally Tailored Diabetes Management Programs
      Athena Philis-Tsimikas, Todd P. Gilmer, James Schultz, Chris Walker, Addie L. Fortmann and Linda C. Gallo
      Clinical Diabetes 2012 Oct; 30 (4): 156-163. https://doi.org/10.2337/diaclin.30.4.156

  2. Shivers, Joseph P.

    1. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
      Lisa S. Rotenstein, Nina Ran, Joseph P. Shivers, Mark Yarchoan and Kelly L. Close
      Clinical Diabetes 2012 Oct; 30 (4): 138-150. https://doi.org/10.2337/diaclin.30.4.138

  3. Simmons, Lisa R.

    1. Diabetic Ketoacidosis as a Presenting Feature of Acromegaly: When Excess Hormone Meets Hormone Deficiency
      Lisa R. Simmons, Kiernan Hughes, Tania P. Markovic and Elizabeth L. Chua
      Clinical Diabetes 2012 Oct; 30 (4): 170-172. https://doi.org/10.2337/diaclin.30.4.170

T

  1. Tran, Joseph

    1. Smartphone-Based Glucose Monitors and Applications in the Management of Diabetes: An Overview of 10 Salient “Apps” and a Novel Smartphone-Connected Blood Glucose Monitor
      Joseph Tran, Rosanna Tran and John R. White
      Clinical Diabetes 2012 Oct; 30 (4): 173-178. https://doi.org/10.2337/diaclin.30.4.173

  2. Tran, Rosanna

    1. Smartphone-Based Glucose Monitors and Applications in the Management of Diabetes: An Overview of 10 Salient “Apps” and a Novel Smartphone-Connected Blood Glucose Monitor
      Joseph Tran, Rosanna Tran and John R. White
      Clinical Diabetes 2012 Oct; 30 (4): 173-178. https://doi.org/10.2337/diaclin.30.4.173

U

  1. Unger, Jeff

    1. Intensification of Type 2 Diabetes in Adolescents: Guess What? Exercise Wins!
      Jeff Unger
      Clinical Diabetes 2012 Oct; 30 (4): 164-167. https://doi.org/10.2337/diaclin.30.4.164

V

  1. Valentine, Virginia

    1. The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management
      Virginia Valentine
      Clinical Diabetes 2012 Oct; 30 (4): 151-155. https://doi.org/10.2337/diaclin.30.4.151

W

  1. Wales, Jerry K. H.

    1. Pitfalls in Diagnosing the Simultaneous Presentation of Type 1 Diabetes and Thyrotoxicosis in a Pediatric Patient
      Tafadzwa Makaya, Jerry K. H. Wales and Katherine J. Price
      Clinical Diabetes 2012 Oct; 30 (4): 168-169. https://doi.org/10.2337/diaclin.30.4.168

  2. Walker, Chris

    1. Community-Created Programs: Can They Be the Basis of Innovative Transformations in Our Health Care Practice? Implications from 15 Years of Testing, Translating, and Implementing Community-Based, Culturally Tailored Diabetes Management Programs
      Athena Philis-Tsimikas, Todd P. Gilmer, James Schultz, Chris Walker, Addie L. Fortmann and Linda C. Gallo
      Clinical Diabetes 2012 Oct; 30 (4): 156-163. https://doi.org/10.2337/diaclin.30.4.156

  3. White, John R.

    1. Smartphone-Based Glucose Monitors and Applications in the Management of Diabetes: An Overview of 10 Salient “Apps” and a Novel Smartphone-Connected Blood Glucose Monitor
      Joseph Tran, Rosanna Tran and John R. White
      Clinical Diabetes 2012 Oct; 30 (4): 173-178. https://doi.org/10.2337/diaclin.30.4.173

Y

  1. Yarchoan, Mark

    1. Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
      Lisa S. Rotenstein, Nina Ran, Joseph P. Shivers, Mark Yarchoan and Kelly L. Close
      Clinical Diabetes 2012 Oct; 30 (4): 138-150. https://doi.org/10.2337/diaclin.30.4.138
Back to top